ETF Exchange > IBB ETF
IBB - ETF Fact Sheet
iShares Biotechnology ETF - USD
Fund Identification
Ticker
IBB
ISIN
US4642875565
Main Metrics
Price
$202.01Expense Ratio
0.44%AuM
$10,514.77MTracking Difference
-0.60%Ratings
Trackinsight rating
★★★★★Official Investment Strategy
The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.
IBB's historical prices, performance, and flows
1m returns
-0.03%
1m flows
$144M
* Net total returns
All data as of 16 October 2026
The ETF Exchange is brought to you by
With data and analysis by
See all IBB data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
IBB's characteristics
Manager
Manager statistics
1813 funds, $6,496.19Bn in AUM
Benchmark
NYSE Biotechnology GTR Index - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
IBB's exposure
Countries
USA
86.08%
Other
13.92%
Sectors
Healthcare
99.97%
Top 5 holdings
Amgen, Inc.
8.45%
Vertex Pharmaceuticals, Inc.
8.05%
Gilead Sciences, Inc.
7.21%
Regeneron Pharmaceuticals, Inc.
5.72%
argenx SE
3.80%
Total holdings
241
Total weight of top 5
33.23%